English

CARACO PHARMACEUTICAL LABORATORIES LTD

EDGAR

Quarterly report (10-Q) · filed 2011-02-09

67 filing records in this dataset, filed from 1996-05-14 to 2011-02-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

40.4 million USD

2010-12-31 · USD

Exact inputs and evidence

Revenue: 40386809 USD Source

Operating margin

-12.36%

2010-12-31 · %

Exact inputs and evidence

Operating Income: -4993701 USD Source
Revenue: 40386809 USD Source

Operating cash flow

514 thousand USD

2010-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 2459717 USD Source
Operating Cash Flow: 1945795 USD Source

Free cash flow

69.1 thousand USD

2010-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 2459717 USD Source
Operating Cash Flow: 1945795 USD Source
Capital Expenditure: 1473200 USD Source
Capital Expenditure: 1028382 USD Source

Cash and cash equivalents: 53.7 million USD 2010-12-31 Source
Exact value

53693785 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

323 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Revenue: 233673688 USD · 2009-04-01 – 2010-03-31 Source
Revenue: 178435869 USD · 2009-04-01 – 2009-12-31 Source
Revenue: 130028760 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 97789846 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 40386809 USD · 2010-10-01 – 2010-12-31 Source

Net income

-6.21 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Net income: -8659632 USD · 2009-04-01 – 2010-03-31 Source
Net income: -5787829 USD · 2009-04-01 – 2009-12-31 Source
Net income: 1209768 USD · 2010-04-01 – 2010-06-30 Source
Net income: -1507816 USD · 2010-07-01 – 2010-09-30 Source
Net income: -3035268 USD · 2010-10-01 – 2010-12-31 Source

Operating cash flow

-7.39 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Operating cash flow: 5683722 USD · 2009-04-01 – 2010-03-31 Source
Operating cash flow: 15530724 USD · 2009-04-01 – 2009-12-31 Source
Operating cash flow: 3272486 USD · 2010-04-01 – 2010-06-30 Source
Operating cash flow: 1945795 USD · 2010-04-01 – 2010-09-30 Source
Operating cash flow: 3272486 USD · 2010-04-01 – 2010-06-30 Source
Operating cash flow: 2459717 USD · 2010-04-01 – 2010-12-31 Source
Operating cash flow: 1945795 USD · 2010-04-01 – 2010-09-30 Source

Capital expenditure

2.2 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Capital expenditure: 3077021 USD · 2009-04-01 – 2010-03-31 Source
Capital expenditure: 2354225 USD · 2009-04-01 – 2009-12-31 Source
Capital expenditure: 718731 USD · 2010-04-01 – 2010-06-30 Source
Capital expenditure: 1028382 USD · 2010-04-01 – 2010-09-30 Source
Capital expenditure: 718731 USD · 2010-04-01 – 2010-06-30 Source
Capital expenditure: 1473200 USD · 2010-04-01 – 2010-12-31 Source
Capital expenditure: 1028382 USD · 2010-04-01 – 2010-09-30 Source

Free cash flow

-9.58 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Operating cash flow: 5683722 USD · 2009-04-01 – 2010-03-31 Source
Operating cash flow: 15530724 USD · 2009-04-01 – 2009-12-31 Source
Operating cash flow: 3272486 USD · 2010-04-01 – 2010-06-30 Source
Operating cash flow: 1945795 USD · 2010-04-01 – 2010-09-30 Source
Operating cash flow: 3272486 USD · 2010-04-01 – 2010-06-30 Source
Operating cash flow: 2459717 USD · 2010-04-01 – 2010-12-31 Source
Operating cash flow: 1945795 USD · 2010-04-01 – 2010-09-30 Source
Capital expenditure: 3077021 USD · 2009-04-01 – 2010-03-31 Source
Capital expenditure: 2354225 USD · 2009-04-01 – 2009-12-31 Source
Capital expenditure: 718731 USD · 2010-04-01 – 2010-06-30 Source
Capital expenditure: 1028382 USD · 2010-04-01 – 2010-09-30 Source
Capital expenditure: 718731 USD · 2010-04-01 – 2010-06-30 Source
Capital expenditure: 1473200 USD · 2010-04-01 – 2010-12-31 Source
Capital expenditure: 1028382 USD · 2010-04-01 – 2010-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-02-09.

Financial data available through: 2010-03-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2010-03-31
Operating income: 10 of 11 periods available· newest 2010-03-31
Net income: 10 of 11 periods available· newest 2010-03-31
Operating cash flow: 10 of 11 periods available· newest 2010-03-31
Capital expenditure: 10 of 11 periods available· newest 2010-03-31
Total assets: 10 of 11 periods available· newest 2010-03-31
Total liabilities: 10 of 11 periods available· newest 2010-03-31
Current assets: 10 of 11 periods available· newest 2010-03-31
Current liabilities: 8 of 11 periods available· newest 2010-03-31
Cash and cash equivalents: 10 of 11 periods available· newest 2010-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-30.7%

Prior period

USD 337.18 million

2008-04-01 – 2009-03-31
Current period

USD 233.67 million

2009-04-01 – 2010-03-31

Exact inputs and evidence

233673688 − 337177482 = -103503794 USD

337177482 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
233673688 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Year-over-year change in Revenue: -103503794 USD Concept: fundies:Revenue Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 233673688 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#7462 Input fundies:Revenue: 337177482 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#7462
The citation records this snapshot. The page link may show a newer release later.
Net income
-142.2%

Prior period

USD 20.54 million

2008-04-01 – 2009-03-31
Current period

−USD 8.66 million

2009-04-01 – 2010-03-31

Exact inputs and evidence

-8659632 − 20536579 = -29196211 USD

20536579 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
-8659632 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Year-over-year change in Net income: -29196211 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8659632 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9018 Input fundies:NetIncome: 20536579 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9018
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-69.6%

Prior period

USD 18.71 million

2008-04-01 – 2009-03-31
Current period

USD 5.68 million

2009-04-01 – 2010-03-31

Exact inputs and evidence

5683722 − 18705473 = -13021751 USD

18705473 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
5683722 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Year-over-year change in Operating cash flow: -13021751 USD Concept: fundies:OperatingCashFlow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5683722 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 Input fundies:OperatingCashFlow: 18705473 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-88.5%

Prior period

USD 26.85 million

2008-04-01 – 2009-03-31
Current period

USD 3.08 million

2009-04-01 – 2010-03-31

Exact inputs and evidence

3077021 − 26852537 = -23775516 USD

26852537 USD · 2008-04-01 – 2009-03-31
Inspect prior input Prior source
3077021 USD · 2009-04-01 – 2010-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Year-over-year change in Capital expenditure: -23775516 USD Concept: fundies:CapitalExpenditure Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3077021 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 Input fundies:CapitalExpenditure: 26852537 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-04-01 – 2010-03-31

Revenue USD 233.67 million 100% of revenue
Operating costs Derived USD 246.96 million 106% of revenue
Operating income −USD 13.29 million −5.7% of revenue
Tax, interest and other Derived −USD 4.63 million −2% of revenue
Net income −USD 8.66 million −3.7% of revenue

Cash

Operating cash flow USD 5.68 million 2.4% of revenue
Capital expenditure USD 3.08 million 1.3% of revenue
Free cash flow Derived USD 2.61 million 1.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 357% of revenue.
2001 Operating loss: operating costs were 168% of revenue.
2002 Operating loss: operating costs were 103% of revenue.
2003 25%73%
2004 Net loss: net income was −0.3% of revenue.
2006 Operating loss: operating costs were 113% of revenue.
2007 Net income was higher than operating income, so the split is not drawn.
2008 10%88%
2009 91%
2010 Operating loss: operating costs were 106% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	2377546	8483072 Derived	-6105526	1517182 Derived	-7622708	-6658751 Derived	Source 2000-01-01 – 2000-12-31: 2377546 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -6105526 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -7622708 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -6443292 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 215459 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	5922431	9946357 Derived	-4023926	1733537 Derived	-5757463	-7195658 Derived	Source 2001-01-01 – 2001-12-31: 5922431 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -4023926 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -5757463 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -7087127 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 108531 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	22380964	23111329 Derived	-730365	1525639 Derived	-2256004	-2431402 Derived	Source 2002-01-01 – 2002-12-31: 22380964 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -730365 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -2256004 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -838600 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1592802 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	45498400	33086411 Derived	12411989	1189271 Derived	11222718	13015318 Derived	Source 2003-01-01 – 2003-12-31: 45498400 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 12411989 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 11222718 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 15508491 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 2493173 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	60340309	60168698 Derived	171611	370979 Derived	-199368	18056731 Derived	Source 2004-01-01 – 2004-12-31: 60340309 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 171611 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -199368 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 22039144 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3982413 USD Inspect Capital Expenditure Open source
2006 2005-04-01 – 2006-03-31	82788918	93548250 Derived	-10759332	-336020 Derived	-10423312	5236210 Derived	Source 2005-04-01 – 2006-03-31: 82788918 USD Inspect Revenue Open source 2005-04-01 – 2006-03-31: -10759332 USD Inspect Operating Income Open source 2005-04-01 – 2006-03-31: -10423312 USD Inspect Net Income Open source 2005-04-01 – 2006-03-31: 8852111 USD Inspect Operating Cash Flow Open source 2005-04-01 – 2006-03-31: 3615901 USD Inspect Capital Expenditure Open source
2007 2006-04-01 – 2007-03-31	117027016	91475455 Derived	25551561	-1306560 Derived	26858121	21923407 Derived	Source 2006-04-01 – 2007-03-31: 117027016 USD Inspect Revenue Open source 2006-04-01 – 2007-03-31: 25551561 USD Inspect Operating Income Open source 2006-04-01 – 2007-03-31: 26858121 USD Inspect Net Income Open source 2006-04-01 – 2007-03-31: 27929421 USD Inspect Operating Cash Flow Open source 2006-04-01 – 2007-03-31: 6006014 USD Inspect Capital Expenditure Open source
2008 2007-04-01 – 2008-03-31	350366689	309660625 Derived	40706064	5317959 Derived	35388105	22685615 Derived	Source 2007-04-01 – 2008-03-31: 350366689 USD Inspect Revenue Open source 2007-04-01 – 2008-03-31: 40706064 USD Inspect Operating Income Open source 2007-04-01 – 2008-03-31: 35388105 USD Inspect Net Income Open source 2007-04-01 – 2008-03-31: 27779646 USD Inspect Operating Cash Flow Open source 2007-04-01 – 2008-03-31: 5094031 USD Inspect Capital Expenditure Open source
2009 2008-04-01 – 2009-03-31	337177482	308328402 Derived	28849080	8312501 Derived	20536579	-8147064 Derived	Source 2008-04-01 – 2009-03-31: 337177482 USD Inspect Revenue Open source 2008-04-01 – 2009-03-31: 28849080 USD Inspect Operating Income Open source 2008-04-01 – 2009-03-31: 20536579 USD Inspect Net Income Open source 2008-04-01 – 2009-03-31: 18705473 USD Inspect Operating Cash Flow Open source 2008-04-01 – 2009-03-31: 26852537 USD Inspect Capital Expenditure Open source
2010 2009-04-01 – 2010-03-31	233673688	246962263 Derived	-13288575	-4628943 Derived	-8659632	2606701 Derived	Source 2009-04-01 – 2010-03-31: 233673688 USD Inspect Revenue Open source 2009-04-01 – 2010-03-31: -13288575 USD Inspect Operating Income Open source 2009-04-01 – 2010-03-31: -8659632 USD Inspect Net Income Open source 2009-04-01 – 2010-03-31: 5683722 USD Inspect Operating Cash Flow Open source 2009-04-01 – 2010-03-31: 3077021 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 233.7M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	2377546	Revenue: 2377546 Open source
20012001-12-31	Revenue	5922431	Revenue: 5922431 Open source
20022002-12-31	Revenue	22380964	Revenue: 22380964 Open source
20032003-12-31	Revenue	45498400	Revenue: 45498400 Open source
20042004-12-31	Revenue	60340309	Revenue: 60340309 Open source
20062006-03-31	Revenue	82788918	Revenue: 82788918 Open source
20072007-03-31	Revenue	117027016	Revenue: 117027016 Open source
20082008-03-31	Revenue	350366689	Revenue: 350366689 Open source
20092009-03-31	Revenue	337177482	Revenue: 337177482 Open source
20102010-03-31	Revenue	233673688	Revenue: 233673688 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-30.7% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 2377546 Open source
20012001-12-31	Year over year	149.1%	Revenue: 5922431 Open source Revenue: 2377546 Open source
20022002-12-31	Year over year	277.9%	Revenue: 22380964 Open source Revenue: 5922431 Open source
20032003-12-31	Year over year	103.3%	Revenue: 45498400 Open source Revenue: 22380964 Open source
20042004-12-31	Year over year	32.6%	Revenue: 60340309 Open source Revenue: 45498400 Open source
20062006-03-31	Year over year	No prior comparable period	Revenue: 82788918 Open source
20072007-03-31	Year over year	41.4%	Revenue: 117027016 Open source Revenue: 82788918 Open source
20082008-03-31	Year over year	199.4%	Revenue: 350366689 Open source Revenue: 117027016 Open source
20092009-03-31	Year over year	-3.8%	Revenue: 337177482 Open source Revenue: 350366689 Open source
20102010-03-31	Year over year	-30.7%	Revenue: 233673688 Open source Revenue: 337177482 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -5.7% 2010

Net margin -3.7% 2010

Free cash flow margin 1.1% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	-256.8%	Operating Income: -6105526 Open source Revenue: 2377546 Open source
20012001-12-31	Operating margin	-67.9%	Operating Income: -4023926 Open source Revenue: 5922431 Open source
20022002-12-31	Operating margin	-3.3%	Operating Income: -730365 Open source Revenue: 22380964 Open source
20032003-12-31	Operating margin	27.3%	Operating Income: 12411989 Open source Revenue: 45498400 Open source
20042004-12-31	Operating margin	0.3%	Operating Income: 171611 Open source Revenue: 60340309 Open source
20062006-03-31	Operating margin	-13%	Operating Income: -10759332 Open source Revenue: 82788918 Open source
20072007-03-31	Operating margin	21.8%	Operating Income: 25551561 Open source Revenue: 117027016 Open source
20082008-03-31	Operating margin	11.6%	Operating Income: 40706064 Open source Revenue: 350366689 Open source
20092009-03-31	Operating margin	8.6%	Operating Income: 28849080 Open source Revenue: 337177482 Open source
20102010-03-31	Operating margin	-5.7%	Operating Income: -13288575 Open source Revenue: 233673688 Open source
20002000-12-31	Net margin	-320.6%	Net Income: -7622708 Open source Revenue: 2377546 Open source
20012001-12-31	Net margin	-97.2%	Net Income: -5757463 Open source Revenue: 5922431 Open source
20022002-12-31	Net margin	-10.1%	Net Income: -2256004 Open source Revenue: 22380964 Open source
20032003-12-31	Net margin	24.7%	Net Income: 11222718 Open source Revenue: 45498400 Open source
20042004-12-31	Net margin	-0.3%	Net Income: -199368 Open source Revenue: 60340309 Open source
20062006-03-31	Net margin	-12.6%	Net Income: -10423312 Open source Revenue: 82788918 Open source
20072007-03-31	Net margin	23%	Net Income: 26858121 Open source Revenue: 117027016 Open source
20082008-03-31	Net margin	10.1%	Net Income: 35388105 Open source Revenue: 350366689 Open source
20092009-03-31	Net margin	6.1%	Net Income: 20536579 Open source Revenue: 337177482 Open source
20102010-03-31	Net margin	-3.7%	Net Income: -8659632 Open source Revenue: 233673688 Open source
20002000-12-31	Free cash flow margin	-280.1%	Revenue: 2377546 Open source Operating Cash Flow: -6443292 Open source Capital Expenditure: 215459 Open source
20012001-12-31	Free cash flow margin	-121.5%	Revenue: 5922431 Open source Operating Cash Flow: -7087127 Open source Capital Expenditure: 108531 Open source
20022002-12-31	Free cash flow margin	-10.9%	Revenue: 22380964 Open source Operating Cash Flow: -838600 Open source Capital Expenditure: 1592802 Open source
20032003-12-31	Free cash flow margin	28.6%	Revenue: 45498400 Open source Operating Cash Flow: 15508491 Open source Capital Expenditure: 2493173 Open source
20042004-12-31	Free cash flow margin	29.9%	Revenue: 60340309 Open source Operating Cash Flow: 22039144 Open source Capital Expenditure: 3982413 Open source
20062006-03-31	Free cash flow margin	6.3%	Revenue: 82788918 Open source Operating Cash Flow: 8852111 Open source Capital Expenditure: 3615901 Open source
20072007-03-31	Free cash flow margin	18.7%	Revenue: 117027016 Open source Operating Cash Flow: 27929421 Open source Capital Expenditure: 6006014 Open source
20082008-03-31	Free cash flow margin	6.5%	Revenue: 350366689 Open source Operating Cash Flow: 27779646 Open source Capital Expenditure: 5094031 Open source
20092009-03-31	Free cash flow margin	-2.4%	Revenue: 337177482 Open source Operating Cash Flow: 18705473 Open source Capital Expenditure: 26852537 Open source
20102010-03-31	Free cash flow margin	1.1%	Revenue: 233673688 Open source Operating Cash Flow: 5683722 Open source Capital Expenditure: 3077021 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 5.7M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	-6443292	Operating Cash Flow: -6443292 Open source
20012001-12-31	Operating cash flow	-7087127	Operating Cash Flow: -7087127 Open source
20022002-12-31	Operating cash flow	-838600	Operating Cash Flow: -838600 Open source
20032003-12-31	Operating cash flow	15508491	Operating Cash Flow: 15508491 Open source
20042004-12-31	Operating cash flow	22039144	Operating Cash Flow: 22039144 Open source
20062006-03-31	Operating cash flow	8852111	Operating Cash Flow: 8852111 Open source
20072007-03-31	Operating cash flow	27929421	Operating Cash Flow: 27929421 Open source
20082008-03-31	Operating cash flow	27779646	Operating Cash Flow: 27779646 Open source
20092009-03-31	Operating cash flow	18705473	Operating Cash Flow: 18705473 Open source
20102010-03-31	Operating cash flow	5683722	Operating Cash Flow: 5683722 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 2.6M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	-6658751	Operating Cash Flow: -6443292 Open source Capital Expenditure: 215459 Open source
20012001-12-31	Free cash flow	-7195658	Operating Cash Flow: -7087127 Open source Capital Expenditure: 108531 Open source
20022002-12-31	Free cash flow	-2431402	Operating Cash Flow: -838600 Open source Capital Expenditure: 1592802 Open source
20032003-12-31	Free cash flow	13015318	Operating Cash Flow: 15508491 Open source Capital Expenditure: 2493173 Open source
20042004-12-31	Free cash flow	18056731	Operating Cash Flow: 22039144 Open source Capital Expenditure: 3982413 Open source
20062006-03-31	Free cash flow	5236210	Operating Cash Flow: 8852111 Open source Capital Expenditure: 3615901 Open source
20072007-03-31	Free cash flow	21923407	Operating Cash Flow: 27929421 Open source Capital Expenditure: 6006014 Open source
20082008-03-31	Free cash flow	22685615	Operating Cash Flow: 27779646 Open source Capital Expenditure: 5094031 Open source
20092009-03-31	Free cash flow	-8147064	Operating Cash Flow: 18705473 Open source Capital Expenditure: 26852537 Open source
20102010-03-31	Free cash flow	2606701	Operating Cash Flow: 5683722 Open source Capital Expenditure: 3077021 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

54% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Liabilities / assets	285.7%	Total Liabilities: 26350988 Open source Total Assets: 9222752 Open source
20012001-12-31	Liabilities / assets	299.4%	Total Liabilities: 34455205 Open source Total Assets: 11509956 Open source
20022002-12-31	Liabilities / assets	198.8%	Total Liabilities: 39476439 Open source Total Assets: 19853149 Open source
20032003-12-31	Liabilities / assets	117.5%	Total Liabilities: 33403681 Open source Total Assets: 28424269 Open source
20042004-12-31	Liabilities / assets	31.1%	Total Liabilities: 11627414 Open source Total Assets: 37402990 Open source
20062006-03-31	Liabilities / assets	27%	Total Liabilities: 20863748 Open source Total Assets: 77241999 Open source
20072007-03-31	Liabilities / assets	16.8%	Total Liabilities: 19275883 Open source Total Assets: 114469292 Open source
20082008-03-31	Liabilities / assets	73.5%	Total Liabilities: 395494873 Open source Total Assets: 538275186 Open source
20092009-03-31	Liabilities / assets	30.7%	Total Liabilities: 72664868 Open source Total Assets: 236488323 Open source
20102010-03-31	Liabilities / assets	54%	Total Liabilities: 182712906 Open source Total Assets: 338098771 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.49× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	0.19×	Current Assets: 2128519 Open source Current Liabilities: 11310988 Open source
20012001-12-31	Current assets / current liabilities	0.44×	Current Assets: 4815874 Open source Current Liabilities: 10855205 Open source
20022002-12-31	Current assets / current liabilities	0.88×	Current Assets: 12105639 Open source Current Liabilities: 13752892 Open source
20032003-12-31	Current assets / current liabilities	0.95×	Current Assets: 18917594 Open source Current Liabilities: 20008404 Open source
20042004-12-31	Current assets / current liabilities	2.14×	Current Assets: 24856957 Open source Current Liabilities: 11627414 Open source
20062006-03-31	Current assets / current liabilities	Not reported	Current Assets: 62281595 Open source
20072007-03-31	Current assets / current liabilities	Not reported	Current Assets: 95439405 Open source
20082008-03-31	Current assets / current liabilities	1.26×	Current Assets: 500021784 Open source Current Liabilities: 395494873 Open source
20092009-03-31	Current assets / current liabilities	2.96×	Current Assets: 169864353 Open source Current Liabilities: 57364868 Open source
20102010-03-31	Current assets / current liabilities	1.49×	Current Assets: 271990778 Open source Current Liabilities: 182712906 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 2000-01-01 – 2000-12-31	−USD 7.62 million Exact value Exact value: -7622708 USD 2000-01-01 – 2000-12-31: -7622708 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2000-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -7622708 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7622708 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-01-001848.txt#1745 The citation records this snapshot. The page link may show a newer release later.	−USD 6.44 million Exact value Exact value: -6443292 USD 2000-01-01 – 2000-12-31: -6443292 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2000-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: -6443292 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6443292 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-01-001848.txt#1760 The citation records this snapshot. The page link may show a newer release later.	USD 215,459 Exact value Exact value: 215459 USD 2000-01-01 – 2000-12-31: 215459 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2000-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 215459 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 215459 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-01-001848.txt#1763 The citation records this snapshot. The page link may show a newer release later.	−USD 6.66 million Calculation and evidence -6443292 − 215459 USD Exact free cash flow: -6658751 USD 2000-01-01 – 2000-12-31: -6443292 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 215459 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2000-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: -6658751 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6443292 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-01-001848.txt#1760 Input fundies:CapitalExpenditure: 215459 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-01-001848.txt#1763 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 5.76 million Exact value Exact value: -5757463 USD 2001-01-01 – 2001-12-31: -5757463 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2001-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -5757463 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5757463 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-03-001024.txt#2186 The citation records this snapshot. The page link may show a newer release later.	−USD 7.09 million Exact value Exact value: -7087127 USD 2001-01-01 – 2001-12-31: -7087127 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2001-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: -7087127 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7087127 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-03-001024.txt#2200 The citation records this snapshot. The page link may show a newer release later.	USD 108,531 Exact value Exact value: 108531 USD 2001-01-01 – 2001-12-31: 108531 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2001-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 108531 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 108531 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-03-001024.txt#2203 The citation records this snapshot. The page link may show a newer release later.	−USD 7.2 million Calculation and evidence -7087127 − 108531 USD Exact free cash flow: -7195658 USD 2001-01-01 – 2001-12-31: -7087127 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 108531 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2001-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: -7195658 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7087127 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-03-001024.txt#2200 Input fundies:CapitalExpenditure: 108531 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0000950124-03-001024.txt#2203 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 2.26 million Exact value Exact value: -2256004 USD 2002-01-01 – 2002-12-31: -2256004 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2002-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -2256004 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2256004 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-05-001668.txt#5814 The citation records this snapshot. The page link may show a newer release later.	−USD 838,600 Exact value Exact value: -838600 USD 2002-01-01 – 2002-12-31: -838600 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2002-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: -838600 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -838600 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-05-001668.txt#6030 The citation records this snapshot. The page link may show a newer release later.	USD 1.59 million Exact value Exact value: 1592802 USD 2002-01-01 – 2002-12-31: 1592802 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2002-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 1592802 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1592802 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-05-001668.txt#6066 The citation records this snapshot. The page link may show a newer release later.	−USD 2.43 million Calculation and evidence -838600 − 1592802 USD Exact free cash flow: -2431402 USD 2002-01-01 – 2002-12-31: -838600 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1592802 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2002-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: -2431402 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -838600 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-05-001668.txt#6030 Input fundies:CapitalExpenditure: 1592802 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-05-001668.txt#6066 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 11.22 million Exact value Exact value: 11222718 USD 2003-01-01 – 2003-12-31: 11222718 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2003-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: 11222718 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 11222718 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-06-002766.txt#17103 The citation records this snapshot. The page link may show a newer release later.	USD 15.51 million Exact value Exact value: 15508491 USD 2003-01-01 – 2003-12-31: 15508491 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2003-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 15508491 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15508491 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-06-002766.txt#17735 The citation records this snapshot. The page link may show a newer release later.	USD 2.49 million Exact value Exact value: 2493173 USD 2003-01-01 – 2003-12-31: 2493173 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2003-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 2493173 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2493173 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-06-002766.txt#17869 The citation records this snapshot. The page link may show a newer release later.	USD 13.02 million Calculation and evidence 15508491 − 2493173 USD Exact free cash flow: 13015318 USD 2003-01-01 – 2003-12-31: 15508491 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 2493173 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2003-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 13015318 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15508491 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-06-002766.txt#17735 Input fundies:CapitalExpenditure: 2493173 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-06-002766.txt#17869 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 199,368 Exact value Exact value: -199368 USD 2004-01-01 – 2004-12-31: -199368 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2004-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -199368 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -199368 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-07-002329.txt#18315 The citation records this snapshot. The page link may show a newer release later.	USD 22.04 million Exact value Exact value: 22039144 USD 2004-01-01 – 2004-12-31: 22039144 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2004-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 22039144 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22039144 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-07-002329.txt#18902 The citation records this snapshot. The page link may show a newer release later.	USD 3.98 million Exact value Exact value: 3982413 USD 2004-01-01 – 2004-12-31: 3982413 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2004-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 3982413 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3982413 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-07-002329.txt#19036 The citation records this snapshot. The page link may show a newer release later.	USD 18.06 million Calculation and evidence 22039144 − 3982413 USD Exact free cash flow: 18056731 USD 2004-01-01 – 2004-12-31: 22039144 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3982413 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2004-12-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 18056731 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 22039144 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-07-002329.txt#18902 Input fundies:CapitalExpenditure: 3982413 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-07-002329.txt#19036 The citation records this snapshot. The page link may show a newer release later.
2006 2005-04-01 – 2006-03-31	−USD 10.42 million Exact value Exact value: -10423312 USD 2005-04-01 – 2006-03-31: -10423312 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2006-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -10423312 USD Concept: fundies:NetIncome Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:NetIncome: -10423312 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-08-002293.txt#20955 The citation records this snapshot. The page link may show a newer release later.	USD 8.85 million Exact value Exact value: 8852111 USD 2005-04-01 – 2006-03-31: 8852111 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2006-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 8852111 USD Concept: fundies:OperatingCashFlow Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8852111 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-08-002293.txt#21739 The citation records this snapshot. The page link may show a newer release later.	USD 3.62 million Exact value Exact value: 3615901 USD 2005-04-01 – 2006-03-31: 3615901 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2006-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 3615901 USD Concept: fundies:CapitalExpenditure Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2006-03-31&surface=latest&period_type=duration&start=2005-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3615901 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-08-002293.txt#21883 The citation records this snapshot. The page link may show a newer release later.	USD 5.24 million Calculation and evidence 8852111 − 3615901 USD Exact free cash flow: 5236210 USD 2005-04-01 – 2006-03-31: 8852111 USD · Inspect Operating Cash Flow · Source 2005-04-01 – 2006-03-31: 3615901 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2006-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 5236210 USD Concept: free-cash-flow Period: 2005-04-01 to 2006-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8852111 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-08-002293.txt#21739 Input fundies:CapitalExpenditure: 3615901 USD (2005-04-01 to 2006-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-08-002293.txt#21883 The citation records this snapshot. The page link may show a newer release later.
2007 2006-04-01 – 2007-03-31	USD 26.86 million Exact value Exact value: 26858121 USD 2006-04-01 – 2007-03-31: 26858121 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2007-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: 26858121 USD Concept: fundies:NetIncome Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:NetIncome: 26858121 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-09-003031.txt#19322 The citation records this snapshot. The page link may show a newer release later.	USD 27.93 million Exact value Exact value: 27929421 USD 2006-04-01 – 2007-03-31: 27929421 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2007-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 27929421 USD Concept: fundies:OperatingCashFlow Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27929421 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-09-003031.txt#20092 The citation records this snapshot. The page link may show a newer release later.	USD 6.01 million Exact value Exact value: 6006014 USD 2006-04-01 – 2007-03-31: 6006014 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2007-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 6006014 USD Concept: fundies:CapitalExpenditure Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2007-03-31&surface=latest&period_type=duration&start=2006-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6006014 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-09-003031.txt#20264 The citation records this snapshot. The page link may show a newer release later.	USD 21.92 million Calculation and evidence 27929421 − 6006014 USD Exact free cash flow: 21923407 USD 2006-04-01 – 2007-03-31: 27929421 USD · Inspect Operating Cash Flow · Source 2006-04-01 – 2007-03-31: 6006014 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2007-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 21923407 USD Concept: free-cash-flow Period: 2006-04-01 to 2007-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27929421 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-09-003031.txt#20092 Input fundies:CapitalExpenditure: 6006014 USD (2006-04-01 to 2007-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001169232-09-003031.txt#20264 The citation records this snapshot. The page link may show a newer release later.
2008 2007-04-01 – 2008-03-31	USD 35.39 million Exact value Exact value: 35388105 USD 2007-04-01 – 2008-03-31: 35388105 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2008-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: 35388105 USD Concept: fundies:NetIncome Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:NetIncome: 35388105 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9018 The citation records this snapshot. The page link may show a newer release later.	USD 27.78 million Exact value Exact value: 27779646 USD 2007-04-01 – 2008-03-31: 27779646 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2008-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 27779646 USD Concept: fundies:OperatingCashFlow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27779646 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 The citation records this snapshot. The page link may show a newer release later.	USD 5.09 million Exact value Exact value: 5094031 USD 2007-04-01 – 2008-03-31: 5094031 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2008-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 5094031 USD Concept: fundies:CapitalExpenditure Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2008-03-31&surface=latest&period_type=duration&start=2007-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5094031 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.	USD 22.69 million Calculation and evidence 27779646 − 5094031 USD Exact free cash flow: 22685615 USD 2007-04-01 – 2008-03-31: 27779646 USD · Inspect Operating Cash Flow · Source 2007-04-01 – 2008-03-31: 5094031 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2008-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 22685615 USD Concept: free-cash-flow Period: 2007-04-01 to 2008-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27779646 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 Input fundies:CapitalExpenditure: 5094031 USD (2007-04-01 to 2008-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.
2009 2008-04-01 – 2009-03-31	USD 20.54 million Exact value Exact value: 20536579 USD 2008-04-01 – 2009-03-31: 20536579 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2009-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: 20536579 USD Concept: fundies:NetIncome Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:NetIncome: 20536579 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9018 The citation records this snapshot. The page link may show a newer release later.	USD 18.71 million Exact value Exact value: 18705473 USD 2008-04-01 – 2009-03-31: 18705473 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2009-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 18705473 USD Concept: fundies:OperatingCashFlow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 18705473 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 The citation records this snapshot. The page link may show a newer release later.	USD 26.85 million Exact value Exact value: 26852537 USD 2008-04-01 – 2009-03-31: 26852537 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2009-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 26852537 USD Concept: fundies:CapitalExpenditure Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2009-03-31&surface=latest&period_type=duration&start=2008-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26852537 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.	−USD 8.15 million Calculation and evidence 18705473 − 26852537 USD Exact free cash flow: -8147064 USD 2008-04-01 – 2009-03-31: 18705473 USD · Inspect Operating Cash Flow · Source 2008-04-01 – 2009-03-31: 26852537 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2009-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: -8147064 USD Concept: free-cash-flow Period: 2008-04-01 to 2009-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 18705473 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 Input fundies:CapitalExpenditure: 26852537 USD (2008-04-01 to 2009-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.
2010 2009-04-01 – 2010-03-31	−USD 8.66 million Exact value Exact value: -8659632 USD 2009-04-01 – 2010-03-31: -8659632 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Net Income: -8659632 USD Concept: fundies:NetIncome Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ANetIncome&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:NetIncome: -8659632 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9018 The citation records this snapshot. The page link may show a newer release later.	USD 5.68 million Exact value Exact value: 5683722 USD 2009-04-01 – 2010-03-31: 5683722 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Operating Cash Flow: 5683722 USD Concept: fundies:OperatingCashFlow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3AOperatingCashFlow&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5683722 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 The citation records this snapshot. The page link may show a newer release later.	USD 3.08 million Exact value Exact value: 3077021 USD 2009-04-01 – 2010-03-31: 3077021 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Capital Expenditure: 3077021 USD Concept: fundies:CapitalExpenditure Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708/explain?concept=fundies%3ACapitalExpenditure&period=2010-03-31&surface=latest&period_type=duration&start=2009-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3077021 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.	USD 2.61 million Calculation and evidence 5683722 − 3077021 USD Exact free cash flow: 2606701 USD 2009-04-01 – 2010-03-31: 5683722 USD · Inspect Operating Cash Flow · Source 2009-04-01 – 2010-03-31: 3077021 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARACO PHARMACEUTICAL LABORATORIES LTD · 2010-03-31 CARACO PHARMACEUTICAL LABORATORIES LTD (edgar:887708) Free cash flow: 2606701 USD Concept: free-cash-flow Period: 2009-04-01 to 2010-03-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/887708?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5683722 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9280 Input fundies:CapitalExpenditure: 3077021 USD (2009-04-01 to 2010-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/887708/0001140361-10-024874.txt#9326 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

67 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000887708, 887708, edgar:887708

CARACO PHARMACEUTICAL LABORATORIES LTD

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2009-04-01 – 2010-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation